NCT01486628View on ClinicalTrials.gov

Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 22, 2012

Study Completion Date

June 13, 2013

Conditions

Parkinson's Disease

Interventions

DRUG

ND0612

levodopa and carbidopa solution for subcutaneous administration

DRUG

Placebo

Saline solution for SC continuous administration

Trial Locations (1)

Unknown

Hadassah Medical Center, Jerusalem

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NeuroDerm Ltd.

INDUSTRY

NCT01486628 - Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers | Biotech Hunter | Biotech Hunter